SK pharmteco Partners with Ferring Pharmaceuticals to Scale Up Production of ADSTILADRIN® Gene Therapy

Biopharmaceutical contract manufacturer SK pharmteco commits to production, testing, and release of Ferring’s U.S. approved ADSTILADRIN® ...

April 18, 2024 | Thursday | News
GE HealthCare Launches Voluson Signature 20 and 18 Ultrasound Systems Revolutionizing Women's Health Diagnosis

GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence (AI), adv...

April 18, 2024 | Thursday | News
INTERPHEX24: Industry Leaders Redefine Decontamination Protocols for Sterile Product Manufacturing

  The quest for efficiency without compromising safety and compliance is paramount. This was the central theme of the panel discussion titled "Reimag...

April 17, 2024 | Wednesday | Expert Opinion
Industry Titans Illuminate Path to Pharmaceutical Innovation at INTERPHEX 2024

Industry pioneers Maria Batalha, Kevin J. Bittorf, Matthew Mollan, and John Nadzam took center stage at INTERPHEX 2024 to share their expertise and insight...

April 17, 2024 | Wednesday | Expert Opinion
Beckman Coulter Life Sciences Stuns at INTERPHEX 2024 with Game-Changing QbD1200+ TOC Analyzer

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, makes pharmaceutical and biopharmaceutical analysis faster and simp...

April 16, 2024 | Tuesday | News
Colossal Propels Ancient DNA Research, Investing $7.5M to Pioneer Climate Solutions and Biodiversity Preservation

Colossal, the world’s first de-extinction company, today announces progress on its ancient DNA agenda and a go-forward vision to enable critical new ...

April 15, 2024 | Monday | News
Applied BioCode Introduces Groundbreaking STI + Resistance Panel Assay for Research Purposes Only

  Designed to run seamlessly on the BioCode® MDx-3000 system, this multiplex nucleic acid amplification test delivers unparalleled accuracy in id...

April 15, 2024 | Monday | News
Bio-Rad to Invest in Oncocyte for Exclusive Global Transplant Monitoring Technology, Eyeing FDA Clearance and Market Expansion

Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring commercialization - Bio-R...

April 12, 2024 | Friday | News
SimBioSys Launches TumorSight Plan for Enhanced Breast Cancer Surgery Decision Support

SimBioSys®, a leading TechBio company pioneering the fusion of spatial biophysics with artificial intelligence (AI) and computational modeling to redef...

April 10, 2024 | Wednesday | News
Denovo Biopharma's Liafensine Shows Promise in Phase 2b Trial for Treatment-Resistant Depression

Denovo Biopharma LLC (Denovo), a pioneer in applying precision medicine to the development of innovative drugs, today announced positive results for its bi...

April 09, 2024 | Tuesday | News
Nucleai and GoPath Diagnostics Partner to Advance Digital Pathology with AI Integration

Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic o...

April 08, 2024 | Monday | News
Johnson & Johnson Sounds Alarm on TRC Capital Investment's Below-Market Mini-Tender Offer for Company Shares

Johnson & Johnson announced that it has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation of Ontario, Canada to...

April 05, 2024 | Friday | News
Johnson & Johnson Expands Commitment to Advance Health Equity

Johnson & Johnson announced  that it is collaborating with more than 100 community-led health organizations supporting historically marginalized c...

April 04, 2024 | Thursday | News
Biological Dynamics Expands Adoption of ExoVerita™ Pro Under Early Access Program

“Research has shown that exosomes carry important information about human health, but studying them has proven challenging,” remarked Paul R. B...

April 03, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close